This well-interlinked signaling network (Figure 1E) contains nodes already known to have a role in CLL, such as EZH2 and NF-κB, and also identified new pathways not well-associated with CLL (HNF4A and ELAVL1 nodes) [14,15,16]. Here, EZH2 is linked to B-cell chronic lymphocytic leukemia.